© 2020 MJH Life Sciences and OncLive. All rights reserved.
June 15th 2020, 9:23pm
Shella Saint Fleur-Lominy, MD, PhD, discusses targeted pathways in myeloproliferative neoplasms.
June 10th 2020, 1:17am
Faith E. Davies, MD, shares advice on how to best treat patients with relapsed/refractory multiple myeloma.
June 6th 2020, 1:47am
Mohammad Maher Abdul-Hay, MD, discusses the use of the Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) to guide transplant eligibility in acute lymphoblastic leukemia (ALL).
June 5th 2020, 1:13am
Diane M. Simeone, MD, discusses the importance of germline testing in pancreatic cancer.
June 3rd 2020, 1:13am
Aaron E. Katz, MD, FACS, discusses re-classifying low-risk prostate scores with the 17-gene Oncotype DX Genomic Prostate Score.
June 2nd 2020, 1:33am
Aaron E. Katz, MD, FACS, discusses strategies for determining low-risk prostate cancer.
May 22nd 2020, 1:24am
Gareth J. Morgan, MD, PhD, provides insight on determining treatment selection for patients with multiple myeloma.
May 21st 2020, 2:28am
Michael L. Grossbard, MD, discusses the role of maintenance rituximab (Rituxan) in follicular lymphoma.
May 20th 2020, 10:34pm
May 13th 2020, 1:59am
Marc J. Braunstein, MD, PhD, discusses updated results from the GRIFFIN trial in multiple myeloma.